Features of Treatment of Neurological Symptoms & Syndromes and Nosological forms in Persons in the Acute Period of COVID-19 Disease

References

1. Rauf, A., et al. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies. International Journal of Environmental Research and Public Health. 2020; 17(21):8155. DOI: 10.3390/ijerph17218155
2. Magomedova U. G., et al., The Role of Covid-19 in the Acute Respiratory Pathology Formation in Children, Pharmacophore, 2020; 11(5), 61-65.
3. Meinhardt, J., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021; 24, 168-175 DOI: 10.1038/s41593-020-00758-5
4. Odintsova, G. COVID-19 and epilepsy: Russian and international experience. Neurology, Neuropsychiatry, Psychosomatics, 2021, 13(3), 88-92
5. Disser NP, et al. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197-1204. DOI: 10.2106/JBJS.20.00847
6. Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg. 2020;140:49-53. DOI: 10.1016/j.wneu.2020.05.193.
7. Mishununa V V, et al. Computed Quantum Chemical Modeling of the Effect of Nanosilver on Coronavirus COVID-19. Pharmacophore. 2021;12(2):14- 21. DOI: 10.51847/LcTdy7pSqE
8. Li J, Liu HH, Yin XD, Li CC, Wang J. COVID-19 illness and autoimmune diseases: recent insights. Inflamm Res. 2021;70(4):407-428. DOI: 10.1007/s00011-021-01446-1
9. Ayivi, R., et al. COVID-19: Human immune response and the influence of food ingredients and active compounds. Bioactive Compounds in Health and Disease. 2021; 4, 100. DOI: 10.31989/bchd.v4i6.802
10. Rashedi J, et al. Risk Factors for COVID-19 . Infez Med. 2020;28(4):469-474
11. Groiss SJ, et al. Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19 -A Case Series. Front Neurol. 2020;11:574004. DOI: 10.3389/fneur.2020.574004
12. Steardo L Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19 . Transl Psychiatry. 2020;10(1):261. DOI: 10.1038/s41398-020-00949-5
13. To KK, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect. 2021;10(1):507-535. DOI: 10.1080/22221751.2021.1898291
14. Sreepadmanabh M, Sahu AK, Chande A. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci. 2020;45(1):148. DOI: 10.1007/s12038-020-00114-6
15. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19 ): a pictorial review. Eur Radiol. 2020;30(8):4381-4389. DOI: 10.1007/s00330-020-06801-0
16. Chen Y, et al. Aging in COVID-19 : Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. DOI: 10.1016/j.arr.2020.101205.
17. Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19 : Virology, biology and novel laboratory diagnosis. J Gene Med. 2021;23(2):e3303. DOI: 10.1002/jgm.3303
18. Profeta, A., et al. The impact of Corona pandemic on consumer's food consumption. J Consum Prot Food Saf 2021; 16, 305-314 DOI: 10.1007/s00003-021-01341-1
19. Rooney S, Webster A, Paul L. Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation. Phys Ther. 2020;100(10):1717-1729. DOI: 10.1093/ptj/pzaa129
20. Agostini F, Mangone M, Ruiu P, Paolucci T, Santilli V, Bernetti A. Rehabilitation setting during and after COVID-19 : An overview on recommendations. J Rehabil Med. 2021;53(1):jrm00141. DOI: 10.2340/16501977-2776
21. Xu Y, et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020;18(1):322. DOI: 10.1186/s12967-020-02488-5
22. Brusasco C, et al. Galliera CPAP-COVID-19 study group; collaborators of the Galliera CPAP-COVID-19 study group are. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure. Eur Respir J. 2021;17;57(2):2002524. DOI: 10.1183/13993003.02524-2020
23. Ammar A, et al. Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey. Nutrients. 2020;12(6):1583. DOI: 10.3390/nu12061583
24. Maslova, A. Y., et al. Astrocytes and their Phenomenal Possibilities in the Treatment of Various Neurodegenerative Disorders: An Overview, Journal of Pharmaceutical Research International, 2021; 33(33A), 60-68. DOI: 10.9734/jpri/2021/v33i33A31772
25. Magomedov, M. A., et al. A Proposed Insight into the Anti-viral Potential of Silver Nanoparticles against Novel Coronavirus Disease (COVID-19). Journal of Pharmaceutical Research International, 2021; 33(41B), 79-93. DOI: 10.9734/jpri/2021/v33i41B32347
26. Maslova, A. Y., et al. Study of the effect of Baricitinib on the Course of COVID-19. Journal of Pharmaceutical Research International, 2021; 33(35A), 204-213. DOI: 10.9734/jpri/2021/v33i35A31890
27. Jasielski P, Pi?del F, Piwek M, Rocka A, Petit V, Rejdak K. Application of Citicoline in Neurological Disorders: A Systematic Review. Nutrients. 2020;12(10):3113.
28. Oddone F, Ziccardi L, Roberti G, Coppola G, Manni G. Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function. Curr Neuropharmacol. 2018;16(7):919-932. DOI: 10.2174/1570159X15666170703111729
29. Nawaz, R. M. M. A. et al. Biocompatible Nanomaterials in Food Science, Technology, and Nutrient Drug Delivery: Recent Developments and Applications Frontiers in Nutrition, 2022;8, 778155 DOI: 10.3389/fnut.2021.778155
30. Gutnova, T. S., Kompantsev, D. V., Gvozdenko, A. A., Kramarenko, V. N., & Blinov, A. V. VITAMIN D NANOCAPSULATION. Izvestiya vysshikh uchebnykh zavedenii khimiya khimicheskaya tekhnologiya, 2021; 64(5), 98-105. DOI: 10.6060/ivkkt.20216405.6399
31. Rzhepakovsky, IV., et al. Phytochemical Characterization, Antioxidant Activity, and Cytotoxicity of Methanolic Leaf Extract of Chlorophytum Comosum (Green Type) (Thunb.) Jacq. Molecules. 2022; 27(3):762. DOI: 10.3390/molecules27030762
32. Rzhepakovsky, I., et al. Anti-arthritic effect of chicken embryo tissue hydrolyzate against adjuvant arthritis in rats (X-ray microtomographic and histopathological analysis). Food Sci Nutr. 2021 18;9(10):5648-5669. DOI: 10.1002/fsn3.2529
33. Grieb P. Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs. 2014;28(3):185-93. DOI: 10.1007/s40263-014-0144-8
34. McGlade E, Agoston AM, DiMuzio J, Kizaki M, Nakazaki E, Kamiya T, Yurgelun-Todd D. The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males. J Atten Disord. 2019;23(2):121-134. DOI: 10.1177/1087054715593633
35. Gasull T, DeGregorio-Rocasolano N, Zapata A, Trullas R. Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation. J Biol Chem. 2000; 16;275(24):18350-7. DOI: 10.1074/jbc.M910468199.
36. Dempsey RJ, Raghavendra Rao VL. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. J Neurosurg. 2003;98(4):867-73. DOI: 10.3171/jns.2003.98.4.0867
37. Wignall ND, Brown ES. Citicoline in addictive disorders: a review of the literature. Am J Drug Alcohol Abuse. 2014;40(4):262-8. DOI: 10.3109/00952990.2014.925467
38. Barker-Davies RM, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-959. DOI: 10.1136/bjsports-2020-102596
39. Sun T, Guo L, Tian F, Dai T, Xing X, Zhao J, Li Q. Rehabilitation of patients with COVID-19 . Expert Rev Respir Med. 2020;14(12):1249-1256. DOI: 10.1080/17476348.2020.1811687
40. Boraeva, T. T., et al. Dynamics of Diseases of the Upper Digestive Tract in Children, Journal of Pharmaceutical Research International, 2021; 33(38B), 48-57. DOI: 10.9734/jpri/2021/v33i38B32098
41. Wang CC, Chao JK, Chang YH, Chou CL, Kao CL. Care for patients with musculoskeletal pain during the COVID-19 pandemic: Physical therapy and rehabilitation suggestions for pain management. J Chin Med Assoc. 2020;83(9):822-824. DOI: 10.1097/JCMA.0000000000000376
42. Jimeno-Almazan A, et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health. 2021;18(10):5329. DOI: 10.3390/ijerph18105329
43. Turolla A, Rossettini G, Viceconti A, Palese A, Geri T. Musculoskeletal Physical Therapy During the COVID-19 Pandemic: Is Telerehabilitation the Answer? Phys Ther. 2020; 100(8):1260-1264. DOI: 10.1093/ptj/pzaa093
44. Siddiqui, S.A. et al. Anti-Depressant Properties of Crocin Molecules in Saffron. Molecules 2022; 27, 2076. DOI: 10.3390/molecules27072076